InMed’s THCV will bring ample opportunity to the health sector to scale up in the market.

The Potential of Cannabinoids in the Treatment of Alzheimer’s Disease
InMed’s INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Promising early studies demonstrate INM-901’s neuroprotective effects and an ability